{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:53:11Z","timestamp":1794016391076,"version":"4.8.0"},"reference-count":211,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82230018"],"award-info":[{"award-number":["82230018"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008866","name":"Changhai Hospital of Shanghai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008866","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.cancergen.2026.06.005","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:31:36Z","timestamp":1781627496000},"page":"130-159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Prohibitins in cancer: Multifaceted regulators of mitochondrial homeostasis, oncogenic signaling, tumor microenvironment, and therapeutic resistance"],"prefix":"10.1016","volume":"306-307","author":[{"given":"Lijun","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunmei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangrui","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqi","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoshen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4225-9200","authenticated-orcid":false,"given":"Lei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.cancergen.2026.06.005_bib0001","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/jcp.24531","article-title":"Prohibitins role in cellular survival through Ras-Raf-MEK-ERK pathway","volume":"229","author":"Chowdhury","year":"2014","journal-title":"J Cell Physiol"},{"issue":"4","key":"10.1016\/j.cancergen.2026.06.005_bib0002","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.molmed.2005.02.004","article-title":"Prohibitin: a potential target for new therapeutics","volume":"11","author":"Mishra","year":"2005","journal-title":"Trends Mol Med"},{"issue":"2","key":"10.1016\/j.cancergen.2026.06.005_bib0003","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.canlet.2015.09.012","article-title":"Unveiling the potential of prohibitin in cancer","volume":"369","author":"Koushyar","year":"2015","journal-title":"Cancer Lett"},{"issue":"8","key":"10.1016\/j.cancergen.2026.06.005_bib0004","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.tem.2009.04.004","article-title":"Prohibitin and mitochondrial biology","volume":"20","author":"Artal-Sanz","year":"2009","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.cancergen.2026.06.005_bib0005","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s12935-022-02765-x","article-title":"The function of prohibitins in mitochondria and the clinical potentials","volume":"22","author":"Oyang","year":"2022","journal-title":"Cancer Cell Int"},{"issue":"2","key":"10.1016\/j.cancergen.2026.06.005_bib0006","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1582-4934.2006.tb00404.x","article-title":"The prohibitins: emerging roles in diverse functions","volume":"10","author":"Mishra","year":"2006","journal-title":"J Cell Mol Med"},{"issue":"6","key":"10.1016\/j.cancergen.2026.06.005_bib0007","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41419-018-0661-3","article-title":"Significance of prohibitin domain family in tumorigenesis and its implication in cancer diagnosis and treatment","volume":"9","author":"Yang","year":"2018","journal-title":"Cell Death Dis"},{"issue":"3","key":"10.1016\/j.cancergen.2026.06.005_bib0008","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/0006-291X(89)91813-5","article-title":"Isolation of a cDNA that hybrid selects antiproliferative mRNA from rat liver","volume":"164","author":"McClung","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"issue":"55","key":"10.1016\/j.cancergen.2026.06.005_bib0009","doi-asserted-by":"crossref","first-page":"8388","DOI":"10.1038\/sj.onc.1205944","article-title":"Prohibitin co-localizes with Rb in the nucleus and recruits N-CoR and HDAC1 for transcriptional repression","volume":"21","author":"Wang","year":"2002","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.cancergen.2026.06.005_bib0010","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-65078-3","article-title":"Structures of human organellar SPFH protein complexes","volume":"16","author":"Gao","year":"2025","journal-title":"Nat Commun"},{"issue":"19","key":"10.1016\/j.cancergen.2026.06.005_bib0011","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1111\/j.1742-4658.2010.07809.x","article-title":"The role of prohibitin in cell signaling","volume":"277","author":"Mishra","year":"2010","journal-title":"FEBS J"},{"issue":"9","key":"10.1016\/j.cancergen.2026.06.005_bib0012","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s10495-015-1143-z","article-title":"Multifaceted role of prohibitin in cell survival and apoptosis","volume":"20","author":"Peng","year":"2015","journal-title":"Apoptosis"},{"issue":"3","key":"10.1016\/j.cancergen.2026.06.005_bib0013","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"19","key":"10.1016\/j.cancergen.2026.06.005_bib0014","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1016\/j.molcel.2023.09.001","article-title":"Early fate decision for mitochondrially encoded proteins by a molecular triage","volume":"83","author":"Kohler","year":"2023","journal-title":"Mol Cell"},{"issue":"8","key":"10.1016\/j.cancergen.2026.06.005_bib0015","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1074\/jbc.M708232200","article-title":"The PHB1\/2 phosphocomplex is required for mitochondrial homeostasis and survival of human T cells","volume":"283","author":"Ross","year":"2008","journal-title":"J Biol Chem"},{"issue":"23","key":"10.1016\/j.cancergen.2026.06.005_bib0016","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1038\/sj.onc.1202684","article-title":"Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function","volume":"18","author":"Wang","year":"1999","journal-title":"Oncogene"},{"issue":"17","key":"10.1016\/j.cancergen.2026.06.005_bib0017","first-page":"5251","article-title":"Tumor suppression by the prohibitin gene 3\u2032untranslated region RNA in human breast cancer","volume":"63","author":"Manjeshwar","year":"2003","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.cancergen.2026.06.005_bib0018","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41417-025-00883-y","article-title":"Emerging roles of prohibitins in cancer: an update","volume":"32","author":"Gao","year":"2025","journal-title":"Cancer Gene Ther"},{"issue":"12","key":"10.1016\/j.cancergen.2026.06.005_bib0019","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1080\/15548627.2025.2551680","article-title":"KDM4A-induced tumor senescence enhances the efficacy of immunotherapy by inhibiting AGT-PHB1 axis-mediated mitophagy in colorectal cancer","volume":"21","author":"Cai","year":"2025","journal-title":"Autophagy"},{"issue":"10","key":"10.1016\/j.cancergen.2026.06.005_bib0020","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1002\/2211-5463.12966","article-title":"Prohibitin participates in the HIRA complex to promote cell metastasis in breast cancer cell lines","volume":"10","author":"Huang","year":"2020","journal-title":"FEBS Open Bio"},{"issue":"9","key":"10.1016\/j.cancergen.2026.06.005_bib0021","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1002\/ijc.23351","article-title":"Prohibitin silencing reverses stabilization of mitochondrial integrity and chemoresistance in ovarian cancer cells by increasing their sensitivity to apoptosis","volume":"122","author":"Gregory-Bass","year":"2008","journal-title":"Int J Cancer"},{"issue":"8","key":"10.1016\/j.cancergen.2026.06.005_bib0022","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.3390\/cells12081211","article-title":"Essential protein PHB2 and its regulatory mechanisms in cancer","volume":"12","author":"Qi","year":"2023","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.cancergen.2026.06.005_bib0023","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1136\/jmg.2007.055772","article-title":"Clinical and molecular aspects of RAS related disorders","volume":"45","author":"Denayer","year":"2008","journal-title":"J Med Genet"},{"key":"10.1016\/j.cancergen.2026.06.005_bib0024","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.omto.2019.05.005","article-title":"FoxM1 Induced paclitaxel resistance via activation of the FoxM1\/PHB1\/RAF-MEK-ERK pathway and enhancement of the ABCA2 transporter","volume":"14","author":"Huang","year":"2019","journal-title":"Mol Ther Oncolytics"},{"key":"10.1016\/j.cancergen.2026.06.005_bib0025","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1476-4598-13-38","article-title":"Targeting the prohibitin scaffold-CRAF kinase interaction in RAS-ERK-driven pancreatic ductal adenocarcinoma","volume":"13","author":"Luan","year":"2014","journal-title":"Mol Cancer"},{"issue":"8","key":"10.1016\/j.cancergen.2026.06.005_bib0026","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/ncb1283","article-title":"Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration","volume":"7","author":"Rajalingam","year":"2005","journal-title":"Nat Cell Biol"},{"issue":"11","key":"10.1016\/j.cancergen.2026.06.005_bib0027","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.4161\/cc.4.11.2142","article-title":"Ras-Raf signaling needs prohibitin","volume":"4","author":"Rajalingam","year":"2005","journal-title":"Cell Cycle"},{"issue":"6","key":"10.1016\/j.cancergen.2026.06.005_bib0028","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.7150\/ijbs.82361","article-title":"PTPLAD1 Regulates PHB-raf interaction to orchestrate epithelial-mesenchymal and mitofusion-fission transitions in colorectal cancer","volume":"20","author":"Huang","year":"2024","journal-title":"Int J Biol Sci"},{"issue":"2","key":"10.1016\/j.cancergen.2026.06.005_bib0029","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.canlet.2012.02.027","article-title":"Recombinant viral capsid protein VP1 suppresses migration and invasion of human cervical cancer by modulating phosphorylated prohibitin in lipid rafts","volume":"320","author":"Chiu","year":"2012","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.cancergen.2026.06.005_bib0030","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/onc.2012.86","article-title":"Raf activation by Ras and promotion of cellular metastasis require phosphorylation of prohibitin in the raft domain of the plasma membrane","volume":"32","author":"Chiu","year":"2013","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.cancergen.2026.06.005_bib0031","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.7150\/ijbs.82361","article-title":"PTPLAD1 Regulates PHB-raf interaction to orchestrate epithelial-mesenchymal and mitofusion-fission transitions in colorectal cancer","volume":"20","author":"Huang","year":"2024","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.cancergen.2026.06.005_bib0032","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.freeradbiomed.2024.08.028","article-title":"Prohibitin 2 confers NADPH oxidase 1-mediated cytosolic oxidative signaling to promote gastric cancer progression by ERK activation","volume":"224","author":"Xu","year":"2024","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.cancergen.2026.06.005_bib0033","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.ejmech.2018.06.052","article-title":"Targeting prohibitin with small molecules to promote melanogenesis and apoptosis in melanoma cells","volume":"155","author":"Djehal","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.cancergen.2026.06.005_bib0034","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.omto.2019.05.005","article-title":"FoxM1 Induced paclitaxel resistance via activation of the FoxM1\/PHB1\/RAF-MEK-ERK pathway and enhancement of the ABCA2 transporter","volume":"14","author":"Huang","year":"2019","journal-title":"Mol Ther - Oncolytics"},{"issue":"1","key":"10.1016\/j.cancergen.2026.06.005_bib0035","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-021-02116-0","article-title":"STOML2 interacts with PHB through activating MAPK signaling pathway to promote colorectal cancer proliferation","volume":"40","author":"Ma","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.cancergen.2026.06.005_bib0036","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-019-1440-4","article-title":"Prohibitin (PHB) expression is associated with aggressiveness in DLBCL and flavagline-mediated inhibition of cytoplasmic PHB functions induces anti-tumor effects","volume":"38","author":"Bentayeb","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.cancergen.2026.06.005_bib0037","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.chembiol.2012.07.012","article-title":"The natural anticancer compounds rocaglamides inhibit the Raf-MEK-ERK pathway by targeting prohibitin 1 and 2","volume":"19","author":"Polier","year":"2012","journal-title":"Chem Biol"},{"issue":"1","key":"10.1016\/j.cancergen.2026.06.005_bib0038","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13046-023-02695-0","article-title":"Targeting PHB1 to inhibit castration-resistant prostate cancer progression in vitro and in vivo","volume":"42","author":"Liu","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.cancergen.2026.06.005_bib0039","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.3892\/or.2017.5599","article-title":"\u03b2-catenin induces expression of prohibitin gene in acute leukemic cells","volume":"37","author":"Kim","year":"2017","journal-title":"Oncol Rep"},{"issue":"12","key":"10.1016\/j.cancergen.2026.06.005_bib0040","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.244111","article-title":"A subset of flavaglines inhibits KRAS nanoclustering and activation","volume":"133","author":"Yurugi","year":"2020","journal-title":"J Cell Sci"},{"key":"10.1016\/j.cancergen.2026.06.005_bib0041","article-title":"A novel mechanism of salvianolic acid B in postmyocardial infarction cardiac protection: pHB1-driven Raf-ERK pathway activation promotes cardiomyocyte mitosis","volume":"7","author":"Cao","year":"2026","journal-title":"MedComm (2020)"},{"issue":"3","key":"10.1016\/j.cancergen.2026.06.005_bib0042","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.chembiol.2012.12.008","article-title":"A yeast chemical genetic screen identifies inhibitors of human telomerase","volume":"20","author":"Wong","year":"2013","journal-title":"Chem Biol"},{"issue":"1","key":"10.1016\/j.cancergen.2026.06.005_bib0043","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/s13046-019-1440-4","article-title":"Prohibitin (PHB) expression is associated with aggressiveness in DLBCL and flavagline-mediated inhibition of cytoplasmic PHB functions induces anti-tumor effects","volume":"38","author":"Bentayeb","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"issue":"26","key":"10.1016\/j.cancergen.2026.06.005_bib0044","first-page":"3166","article-title":"Inhibition of MYC translation through targeting of the newly identified PHB-eIF4F complex as a therapeutic strategy in CLL","volume":"141","author":"Largeot","year":"2023","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.cancergen.2026.06.005_bib0045","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1007\/s00018-020-03475-1","article-title":"Prohibitin ligands: a growing armamentarium to tackle cancers, osteoporosis, inflammatory, cardiac and neurological diseases","volume":"77","author":"Wang","year":"2020","journal-title":"Cell Mol Life Sci"},{"issue":"16","key":"10.1016\/j.cancergen.2026.06.005_bib0046","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201899429","article-title":"Targeting prohibitins at the cell surface prevents Th17-mediated autoimmunity","volume":"37","author":"Buehler","year":"2018","journal-title":"EMBO J"},{"issue":"7","key":"10.1016\/j.cancergen.2026.06.005_bib0047","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","article-title":"AKT\/PKB signaling: navigating downstream","volume":"129","author":"Manning","year":"2007","journal-title":"Cell"},{"issue":"25","key":"10.1016\/j.cancergen.2026.06.005_bib0048","article-title":"The E3 ubiquitin ligase ARIH1 facilitates colorectal cancer progression by promoting oxidative phosphorylation via the mitochondrial translocation of K63-linked ubiquitinated PHB1","volume":"12","author":"Tong","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.cancergen.2026.06.005_bib0049","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1478-811X-9-22","article-title":"RACK1, A multifaceted scaffolding protein: structure and function","volume":"9","author":"Adams","year":"2011","journal-title":"Cell Commun Signal"},{"issue":"7","key":"10.1016\/j.cancergen.2026.06.005_bib0050","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.7150\/thno.52848","article-title":"PHB2 promotes tumorigenesis via RACK1 in non-small cell lung cancer","volume":"11","author":"Wu","year":"2021","journal-title":"Theranostics"},{"issue":"9","key":"10.1016\/j.cancergen.2026.06.005_bib0051","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1002\/jcb.23146","article-title":"SHIP2 multiple functions: a balance between a negative control of PtdIns(3,4,5)P\u2083 level, a positive control of PtdIns(3,4)P\u2082 production, and intrinsic docking properties","volume":"112","author":"Erneux","year":"2011","journal-title":"J Cell Biochem"},{"issue":"1","key":"10.1016\/j.cancergen.2026.06.005_bib0052","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-023-02937-1","article-title":"PHB2 promotes SHIP2 ubiquitination via the E3 ligase NEDD4 to regulate AKT signaling in gastric cancer","volume":"43","author":"Xu","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.cancergen.2026.06.005_bib0053","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/hep4.1257","article-title":"Prohibitin 1 acts As a negative regulator of wingless\/integrated-beta-catenin signaling in murine liver and Human liver cancer cells","volume":"2","author":"Mavila","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.cancergen.2026.06.005_bib0054","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2017.3307","article-title":"Prohibitin-2 negatively regulates AKT2 expression to promote prostate cancer cell migration","author":"Shen","year":"2017","journal-title":"Int J Mol Med"},{"issue":"14","key":"10.1016\/j.cancergen.2026.06.005_bib0055","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.3390\/cells12141855","article-title":"Targeting prohibitins to inhibit melanoma growth and overcome resistance to targeted therapies","volume":"12","author":"Najem","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.cancergen.2026.06.005_bib0056","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.ejmech.2018.06.052","article-title":"Targeting prohibitin with small molecules to promote melanogenesis and apoptosis in melanoma cells","volume":"155","author":"Djehal","year":"2018","journal-title":"Eur J Med Chem"},{"issue":"3","key":"10.1016\/j.cancergen.2026.06.005_bib0057","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s11684-020-0805-6","article-title":"Prohibitin regulates mTOR pathway via interaction with FKBP8","volume":"15","author":"Zhang","year":"2021","journal-title":"Front Med"},{"issue":"3","key":"10.1016\/j.cancergen.2026.06.005_bib0058","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s11684-020-0805-6","article-title":"Prohibitin regulates mTOR pathway via interaction with FKBP8","volume":"15","author":"Zhang","year":"2021","journal-title":"Front Med"},{"issue":"29","key":"10.1016\/j.cancergen.2026.06.005_bib0059","doi-asserted-by":"crossref","first-page":"9855","DOI":"10.1074\/jbc.RA120.012979","article-title":"The prohibitin-binding compound fluorizoline affects multiple components of the translational machinery and inhibits protein synthesis","volume":"295","author":"Jin","year":"2020","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.cancergen.2026.06.005_bib0060","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13046-018-0695-5","article-title":"Flavagline analog FL3 induces cell cycle arrest in urothelial carcinoma cell of the bladder by inhibiting the Akt\/PHB interaction to activate the GADD45\u03b1 pathway","volume":"37","author":"Yuan","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.cancergen.2026.06.005_bib0061","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13048-022-00999-x","article-title":"Prohibitin 1 interacts with p53 in the regulation of mitochondrial dynamics and chemoresistance in gynecologic cancers","volume":"15","author":"Kong","year":"2022","journal-title":"J Ovarian Res"},{"issue":"5","key":"10.1016\/j.cancergen.2026.06.005_bib0062","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/cas.12654","article-title":"Therapeutic advances in BIG3-PHB2 inhibition targeting the crosstalk between estrogen and growth factors in breast cancer","volume":"106","author":"Yoshimaru","year":"2015","journal-title":"Cancer Sci"},{"issue":"11","key":"10.1016\/j.cancergen.2026.06.005_bib0063","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/s41419-022-05419-y","article-title":"GALNT14-mediated O-glycosylation on PHB2 serine-161 enhances cell growth, migration and drug resistance by activating IGF1R cascade in hepatoma cells","volume":"13","author":"Chu","year":"2022","journal-title":"Cell Death Dis"},{"issue":"12","key":"10.1016\/j.cancergen.2026.06.005_bib0064","doi-asserted-by":"crossref","first-page":"9919","DOI":"10.3390\/ijms24129919","article-title":"Prohibitin links cell cycle, motility and invasion in prostate cancer cells","volume":"24","author":"Koushyar","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.cancergen.2026.06.005_bib0065","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41388-020-01538-y","article-title":"Nuclear partitioning of prohibitin 1 inhibits wnt\/\u03b2-catenin-dependent intestinal tumorigenesis","volume":"40","author":"Alula","year":"2021","journal-title":"Oncogene"},{"issue":"17","key":"10.1016\/j.cancergen.2026.06.005_bib0066","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1158\/0008-5472.CAN-20-0216","article-title":"The synthetic small molecule FL3 combats intestinal tumorigenesis via Axin1-mediated inhibition of wnt\/\u03b2-catenin signaling","volume":"80","author":"Jackson","year":"2020","journal-title":"Cancer Res"},{"issue":"18","key":"10.1016\/j.cancergen.2026.06.005_bib0067","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1007\/s00018-020-03475-1","article-title":"Prohibitin ligands: a growing armamentarium to tackle cancers, osteoporosis, inflammatory, cardiac and neurological diseases","volume":"77","author":"Wang","year":"2020","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"10.1016\/j.cancergen.2026.06.005_bib0068","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-020-00638-x","article-title":"A novel c-kit\/phospho-prohibitin axis enhances ovarian cancer stemness and chemoresistance via Notch3\u2014PBX1 and \u03b2-catenin\u2014ABCG2 signaling","volume":"27","author":"Fang","year":"2020","journal-title":"J Biomed Sci"},{"issue":"25","key":"10.1016\/j.cancergen.2026.06.005_bib0069","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1038\/s41388-019-0778-6","article-title":"LPLUNC1 stabilises PHB1 by counteracting TRIM21-mediated ubiquitination to inhibit NF-\u03bab activity in nasopharyngeal carcinoma","volume":"38","author":"Wang","year":"2019","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.cancergen.2026.06.005_bib0070","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1074\/jbc.RA118.004863","article-title":"The mitochondrial chaperone prohibitin 1 negatively regulates interleukin-8 in human liver cancers","volume":"294","author":"Yang","year":"2019","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.cancergen.2026.06.005_bib0071","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1158\/1541-7786.MCR-22-0415","article-title":"XIAP and PHB1 regulate Anoikis through competitive binding to TRAF6","volume":"21","author":"Yang","year":"2023","journal-title":"Mol Cancer Res"},{"issue":"2","key":"10.1016\/j.cancergen.2026.06.005_bib0072","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41580-024-00785-1","article-title":"Molecular mechanisms of mitochondrial dynamics","volume":"26","author":"T\u00e1bara","year":"2025","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"9","key":"10.1016\/j.cancergen.2026.06.005_bib0073","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.263640","article-title":"Mitochondrial fission - changing perspectives for future progress","volume":"138","author":"Kamerkar","year":"2025","journal-title":"J Cell Sci"},{"issue":"8","key":"10.1016\/j.cancergen.2026.06.005_bib0074","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbabio.2017.01.004","article-title":"Mitochondrial dysfunction and mitochondrial dynamics-the cancer connection","volume":"1858","author":"Srinivasan","year":"2017","journal-title":"Biochim Biophys Acta Bioenerg"},{"issue":"6","key":"10.1016\/j.cancergen.2026.06.005_bib0075","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100067R","article-title":"Mitochondrial fusion and fission: the fine-tune balance for cellular homeostasis","volume":"35","author":"Adebayo","year":"2021","journal-title":"FASEB J"},{"issue":"24","key":"10.1016\/j.cancergen.2026.06.005_bib0076","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022111173","article-title":"Prohibitin 1 regulates mtDNA release and downstream inflammatory responses","volume":"41","author":"Liu","year":"2022","journal-title":"Embo j"},{"issue":"1\u20132","key":"10.1016\/j.cancergen.2026.06.005_bib0077","article-title":"Prohibitin 2 is an inner mitochondrial membrane mitophagy receptor","volume":"168","author":"Wei","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.cancergen.2026.06.005_bib0078","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.108076","article-title":"Prohibitin 1 tethers lipid membranes and regulates OPA1-mediated membrane fusion","volume":"301","author":"Ban","year":"2025","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.cancergen.2026.06.005_bib0079","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1038\/s41418-019-0470-y","article-title":"Mitochondrial 4-HNE derived from MAO-A promotes mitoCa(2+) overload in chronic postischemic cardiac remodeling","volume":"27","author":"Santin","year":"2020","journal-title":"Cell Death Differ"},{"issue":"34","key":"10.1016\/j.cancergen.2026.06.005_bib0080","doi-asserted-by":"crossref","first-page":"12581","DOI":"10.1074\/jbc.RA119.007601","article-title":"In vivo stabilization of OPA1 in hepatocytes potentiates mitochondrial respiration and gluconeogenesis in a prohibitin-dependent way","volume":"294","author":"Li","year":"2019","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.cancergen.2026.06.005_bib0081","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3803\/EnM.2018.33.3.403","article-title":"Deficiency of sphingosine-1-phosphate reduces the expression of prohibitin and causes \u03b2-cell impairment via mitochondrial dysregulation","volume":"33","author":"Hong","year":"2018","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"4","key":"10.1016\/j.cancergen.2026.06.005_bib0082","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/bjd.21698","article-title":"Chronic prurigo","volume":"187","author":"Misery","year":"2022","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.cancergen.2026.06.005_bib0083","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.3390\/ijms23031320","article-title":"The mitochondrial PHB2\/OMA1\/DELE1 pathway cooperates with endoplasmic reticulum stress to facilitate the response to chemotherapeutics in ovarian cancer","volume":"23","author":"Cheng","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"16","key":"10.1016\/j.cancergen.2026.06.005_bib0084","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2023.07.004","article-title":"Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer","volume":"186","author":"Chowdhury","year":"2023","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.cancergen.2026.06.005_bib0085","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1681\/ASN.2018111117","article-title":"Bif-1 interacts with prohibitin-2 to regulate mitochondrial inner membrane during cell stress and apoptosis","volume":"30","author":"Cho","year":"2019","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.cancergen.2026.06.005_bib0086","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/s41419-020-03220-3","article-title":"Prohibitin, STAT3 and SH2D4A physically and functionally interact in tumor cell mitochondria","volume":"11","author":"Ploeger","year":"2020","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.cancergen.2026.06.005_bib0087","doi-asserted-by":"crossref","DOI":"10.1016\/j.mito.2025.102041","article-title":"MiR-718-mediated inhibition of prohibitin 1 influences mitochondrial dynamics, proliferation, and migration of keratinocytes","volume":"84","author":"Rani","year":"2025","journal-title":"Mitochondrion"},{"issue":"1","key":"10.1016\/j.cancergen.2026.06.005_bib0088","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s12964-025-02240-w","article-title":"mTOR inhibition triggers mitochondrial fragmentation in cardiomyocytes through proteosome-dependent prohibitin degradation and OPA-1 cleavage","volume":"23","author":"Verdejo","year":"2025","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.cancergen.2026.06.005_bib0089","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.fsi.2020.06.037","article-title":"Lamprey PHB2 maintains mitochondrial stability by tanslocation to the mitochondria under oxidative stress","volume":"104","author":"Shi","year":"2020","journal-title":"Fish Shellfish Immunol"},{"issue":"1","key":"10.1016\/j.cancergen.2026.06.005_bib0090","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1038\/s41467-021-23552-8","article-title":"Prohibitin 1 is essential to preserve mitochondria and myelin integrity in Schwann cells","volume":"12","author":"Della-Flora Nunes","year":"2021","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.cancergen.2026.06.005_bib0091","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.3390\/cancers11091350","article-title":"Human ovarian cancer tissue exhibits increase of mitochondrial biogenesis and cristae remodeling","volume":"11","author":"Signorile","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.cancergen.2026.06.005_bib0092","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8040085","article-title":"PBMC of multiple sclerosis patients show deregulation of OPA1 processing associated with increased ROS and PHB2 protein levels","volume":"8","author":"De Rasmo","year":"2020","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.cancergen.2026.06.005_bib0093","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/15548627.2019.1628520","article-title":"PHB2 (prohibitin 2) promotes PINK1-PRKN\/parkin-dependent mitophagy by the PARL-PGAM5-PINK1 axis","volume":"16","author":"Yan","year":"2020","journal-title":"Autophagy"},{"issue":"15","key":"10.1016\/j.cancergen.2026.06.005_bib0094","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.127098","article-title":"Prohibitin is a prognostic marker and therapeutic target to block chemotherapy resistance in Wilms' tumor","volume":"4","author":"Ortiz","year":"2019","journal-title":"JCI Insight"},{"issue":"10","key":"10.1016\/j.cancergen.2026.06.005_bib0095","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1110\/ps.0212602","article-title":"A structure for the yeast prohibitin complex: structure prediction and evidence from chemical crosslinking and mass spectrometry","volume":"11","author":"Back","year":"2002","journal-title":"Protein Sci"},{"issue":"3","key":"10.1016\/j.cancergen.2026.06.005_bib0096","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/jnc.14472","article-title":"Prohibitin is a positive modulator of mitochondrial function in PC12 cells under oxidative stress","volume":"146","author":"Anderson","year":"2018","journal-title":"J Neurochem"},{"issue":"5","key":"10.1016\/j.cancergen.2026.06.005_bib0097","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.ajpath.2015.12.018","article-title":"Prohibitin-2 depletion unravels extra-mitochondrial functions at the kidney filtration barrier","volume":"186","author":"Ising","year":"2016","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.cancergen.2026.06.005_bib0098","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1128\/MCB.19.5.3435","article-title":"Prohibitins regulate membrane protein degradation by the m-AAA protease in mitochondria","volume":"19","author":"Steglich","year":"1999","journal-title":"Mol Cell Biol"},{"issue":"10","key":"10.1016\/j.cancergen.2026.06.005_bib0099","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.2337\/db21-0094","article-title":"Prohibitin inactivation in adipocytes results in reduced lipid metabolism and adaptive thermogenesis impairment","volume":"70","author":"Gao","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.cancergen.2026.06.005_bib0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2023.109561","article-title":"Novel effects of prohibitin 1 expression level on cholesterol and lipid homeostasis","volume":"125","author":"Jung","year":"2024","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.cancergen.2026.06.005_bib0101","article-title":"Persistent mTORC1 activation underlies sex dimorphic progression of MASLD in mice with hepatocyte prohibitin-1 deficiency","author":"Alowaisi","year":"2025","journal-title":"Res Sq"},{"key":"10.1016\/j.cancergen.2026.06.005_bib0102","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.714228","article-title":"Role of prohibitins in aging and therapeutic potential against age-related diseases","volume":"12","author":"Belser","year":"2021","journal-title":"Front Genet"},{"issue":"15","key":"10.1016\/j.cancergen.2026.06.005_bib0103","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1242\/jcs.198523","article-title":"Deficiency of PHB complex impairs respiratory supercomplex formation and activates mitochondrial flashes","volume":"130","author":"Jian","year":"2017","journal-title":"J Cell Sci"},{"key":"10.1016\/j.cancergen.2026.06.005_bib0104","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122371","article-title":"Prohibitin 2: a key regulator of cell function","volume":"338","author":"Zhang","year":"2024","journal-title":"Life Sci"},{"issue":"11","key":"10.1016\/j.cancergen.2026.06.005_bib0105","article-title":"Synthesized depside molecules suppress the progression of colorectal cancer by binding VDAC1\/PHB\/MMP9 being at the crossroads of stemness, motility, apoptosis, and metabolism","volume":"6","author":"Varl\u0131","year":"2025","journal-title":"MedComm (2020)"},{"issue":"1","key":"10.1016\/j.cancergen.2026.06.005_bib0106","doi-asserted-by":"crossref","first-page":"11","DOI":"10.15698\/cst2017.10.104","article-title":"VDAC1 at the crossroads of cell metabolism, apoptosis and cell stress","volume":"1","author":"Shoshan-Barmatz","year":"2017","journal-title":"Cell Stress"},{"issue":"3","key":"10.1016\/j.cancergen.2026.06.005_bib0107","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.chembiol.2013.02.006","article-title":"Prohibitin ligands in cell death and survival: mode of action and therapeutic potential","volume":"20","author":"Thuaud","year":"2013","journal-title":"Chem Biol"},{"issue":"1","key":"10.1016\/j.cancergen.2026.06.005_bib0108","doi-asserted-by":"crossref","first-page":"7473","DOI":"10.1038\/s41467-022-35294-2","article-title":"Non-classical ferroptosis inhibition by a small molecule targeting PHB2","volume":"13","author":"Yang","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.cancergen.2026.06.005_bib0109","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s41392-023-01503-7","article-title":"The mitophagy pathway and its implications in human diseases","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"10.1016\/j.cancergen.2026.06.005_bib0110","doi-asserted-by":"crossref","first-page":"R73","DOI":"10.1016\/j.cub.2016.11.055","article-title":"Mitophagy: permitted by Prohibitin","volume":"27","author":"Galluzzi","year":"2017","journal-title":"Curr Biol"},{"issue":"1","key":"10.1016\/j.cancergen.2026.06.005_bib0111","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41598-022-26775-x","article-title":"Inner mitochondrial membrane protein prohibitin 1 mediates Nix-induced, Parkin-independent mitophagy","volume":"13","author":"Alula","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.cancergen.2026.06.005_bib0112","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9233749","article-title":"Nonreceptor tyrosine kinase c-abl-mediated PHB2 phosphorylation aggravates mitophagy disorder in Parkinson's Disease model","volume":"2022","author":"Zhang","year":"2022","journal-title":"Oxid Med Cell Longev"},{"issue":"6","key":"10.1016\/j.cancergen.2026.06.005_bib0113","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202000806","article-title":"Mitochondrial aurora kinase A induces mitophagy by interacting with MAP1LC3 and prohibitin 2","volume":"4","author":"Bertolin","year":"2021","journal-title":"Life Sci Alliance"},{"issue":"1","key":"10.1016\/j.cancergen.2026.06.005_bib0114","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-026-09573-3","article-title":"Development of capsaicin-derived prohibitin ligands to modulate the Aurora kinase A\/PHB2 interaction and mitophagy in cancer cells","volume":"9","author":"Djehal","year":"2026","journal-title":"Commun Biol"},{"issue":"10","key":"10.1016\/j.cancergen.2026.06.005_bib0115","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/s41419-022-05302-w","article-title":"Protein disulfide isomerase blocks the interaction of LC3II-PHB2 and promotes mTOR signaling to regulate autophagy and radio\/chemo-sensitivity","volume":"13","author":"Wang","year":"2022","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.cancergen.2026.06.005_bib0116","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217192","article-title":"Blockade of the lncRNA-PART1-PHB2 axis confers resistance to PARP inhibitor and promotes cellular senescence in ovarian cancer","volume":"602","author":"Wu","year":"2024","journal-title":"Cancer Lett"},{"issue":"10","key":"10.1016\/j.cancergen.2026.06.005_bib0117","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.7150\/thno.55672","article-title":"Cellular senescence in hepatocellular carcinoma induced by a long non-coding RNA-encoded peptide PINT87aa by blocking FOXM1-mediated PHB2","volume":"11","author":"Xiang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.cancergen.2026.06.005_bib0118","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2024.155411","article-title":"Prx1\/PHB2 axis mediates mitophagy in oral leukoplakia cellular senescence","volume":"260","author":"Lu","year":"2024","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.cancergen.2026.06.005_bib0119","article-title":"The landscape of mitophagy in sepsis reveals PHB1 as an NLRP3 inflammasome inhibitor","volume":"14","author":"Chen","year":"2023","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.cancergen.2026.06.005_bib0120","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.40","article-title":"Akt phosphorylates prohibitin 1 to mediate its mitochondrial localization and promote proliferation of bladder cancer cells","volume":"6","author":"Jiang","year":"2015","journal-title":"Cell Death Dis"},{"issue":"10","key":"10.1016\/j.cancergen.2026.06.005_bib0121","doi-asserted-by":"crossref","first-page":"4208","DOI":"10.1111\/cas.15099","article-title":"The survival and proliferation of osteosarcoma cells are dependent on the mitochondrial BIG3-PHB2 complex formation","volume":"112","author":"Toki","year":"2021","journal-title":"Cancer Sci"},{"key":"10.1016\/j.cancergen.2026.06.005_bib0122","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6568748","article-title":"Artemisinin alleviates cerebral ischemia\/reperfusion-induced oxidative damage via regulating PHB2-mediated autophagy in the Human Neuroblastoma SH-SY5Y cell line","volume":"2022","author":"Jiang","year":"2022","journal-title":"Oxid Med Cell Longev"},{"issue":"9","key":"10.1016\/j.cancergen.2026.06.005_bib0123","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41389-021-00352-9","article-title":"The prohibitin-binding compound fluorizoline inhibits mitophagy in cancer cells","volume":"10","author":"N\u00fa\u00f1ez-V\u00e1zquez","year":"2021","journal-title":"Oncogenesis"},{"issue":"3","key":"10.1016\/j.cancergen.2026.06.005_bib0124","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1139\/O09-177","article-title":"Palmitoylation of prohibitin at cysteine 69 facilitates its membrane translocation and interaction with Eps 15 homology domain protein 2 (EHD2)","volume":"88","author":"Ande","year":"2010","journal-title":"Biochem Cell Biol"},{"issue":"13","key":"10.1016\/j.cancergen.2026.06.005_bib0125","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.3390\/ijms26136281","article-title":"UBC9-Mediated SUMO pathway drives prohibitin-1 nuclear accumulation and PITX1 repression in primary osteoarthritis","volume":"26","author":"Doucet","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"20","key":"10.1016\/j.cancergen.2026.06.005_bib0126","doi-asserted-by":"crossref","first-page":"5744","DOI":"10.7150\/thno.28898","article-title":"A positive feedback loop of SLP2 activates MAPK signaling pathway to promote gastric cancer progression","volume":"8","author":"Ma","year":"2018","journal-title":"Theranostics"},{"issue":"12","key":"10.1016\/j.cancergen.2026.06.005_bib0127","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1038\/s41418-024-01392-5","article-title":"HKDC1 functions as a glucose sensor and promotes metabolic adaptation and cancer growth via interaction with PHB2","volume":"31","author":"Liu","year":"2024","journal-title":"Cell Death Differ"},{"issue":"8","key":"10.1016\/j.cancergen.2026.06.005_bib0128","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1111\/j.1349-7006.2009.01209.x","article-title":"Activation of an estrogen\/estrogen receptor signaling by BIG3 through its inhibitory effect on nuclear transport of PHB2\/REA in breast cancer","volume":"100","author":"Kim","year":"2009","journal-title":"Cancer Sci"},{"issue":"6","key":"10.1016\/j.cancergen.2026.06.005_bib0129","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127707","article-title":"BIG3 Inhibits the estrogen-dependent nuclear translocation of PHB2 via multiple karyopherin-alpha proteins in breast cancer cells","volume":"10","author":"Kim","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.cancergen.2026.06.005_bib0130","doi-asserted-by":"crossref","first-page":"511","DOI":"10.4103\/aja.aja_36_18","article-title":"The novel long noncoding RNA LOC283070 is involved in the transition of LNCaP cells into androgen-independent cells via its interaction with PHB2","volume":"20","author":"Zhang","year":"2018","journal-title":"Asian J Androl"},{"issue":"1","key":"10.1016\/j.cancergen.2026.06.005_bib0131","doi-asserted-by":"crossref","first-page":"8385","DOI":"10.1038\/s41467-024-52425-z","article-title":"Prohibitin 2 orchestrates long noncoding RNA and gene transcription to accelerate tumorigenesis","volume":"15","author":"Ding","year":"2024","journal-title":"Nat Commun"},{"issue":"34","key":"10.1016\/j.cancergen.2026.06.005_bib0132","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1038\/onc.2015.501","article-title":"Expression of a mutant prohibitin from the aP2 gene promoter leads to obesity-linked tumor development in insulin resistance-dependent manner","volume":"35","author":"Ande","year":"2016","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.cancergen.2026.06.005_bib0133","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1177\/1535370217703976","article-title":"Prohibitin - At the crossroads of obesity-linked diabetes and cancer","volume":"242","author":"Mishra","year":"2017","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.cancergen.2026.06.005_bib0134","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.canlet.2017.12.001","article-title":"Prohibitin: a new player in immunometabolism and in linking obesity and inflammation with cancer","volume":"415","author":"Zi Xu","year":"2018","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.cancergen.2026.06.005_bib0135","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41419-023-05575-9","article-title":"PHB2 promotes colorectal cancer cell proliferation and tumorigenesis through NDUFS1-mediated oxidative phosphorylation","volume":"14","author":"Ren","year":"2023","journal-title":"Cell Death Dis"},{"issue":"9","key":"10.1016\/j.cancergen.2026.06.005_bib0136","doi-asserted-by":"crossref","DOI":"10.1038\/s41424-018-0044-1","article-title":"A novel prognostic marker and immunogenic membrane antigen: prohibitin (PHB) in pancreatic cancer","volume":"9","author":"Wang","year":"2018","journal-title":"Clin Transl Gastroenterol"},{"issue":"3","key":"10.1016\/j.cancergen.2026.06.005_bib0137","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jhep.2023.11.022","article-title":"Hepatic prohibitin 1 and methionine adenosyltransferase \u03b11 defend against primary and secondary liver cancer metastasis","volume":"80","author":"Fan","year":"2024","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.cancergen.2026.06.005_bib0138","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006778","article-title":"Prohibitin plays a critical role in Enterovirus 71 neuropathogenesis","volume":"14","author":"Too","year":"2018","journal-title":"PLoS Pathog"},{"issue":"10","key":"10.1016\/j.cancergen.2026.06.005_bib0139","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1159\/000509094","article-title":"Aberrant expression of prohibitin is related to prognosis of nasal extranodal natural killer\/T cell lymphoma, nasal type","volume":"43","author":"Guo","year":"2020","journal-title":"Oncol Res Treat"},{"issue":"1","key":"10.1016\/j.cancergen.2026.06.005_bib0140","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12929-020-00639-w","article-title":"Prohibitin 1\/2 mediates Dengue-3 entry into human neuroblastoma (SH-SY5Y) and microglia (CHME-3) cells","volume":"27","author":"Sharma","year":"2020","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.cancergen.2026.06.005_bib0141","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115567","article-title":"Characterization of plasmodium falciparum prohibitins as novel targets to block infection in humans by impairing the growth and transmission of the parasite","volume":"212","author":"Saini","year":"2023","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.cancergen.2026.06.005_bib0142","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/1535370219828362","article-title":"Prohibitin: a hypothetical target for sex-based new therapeutics for metabolic and immune diseases","volume":"244","author":"Mishra","year":"2019","journal-title":"Exp Biol Med (Maywood)"},{"issue":"8","key":"10.1016\/j.cancergen.2026.06.005_bib0143","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.tem.2016.05.003","article-title":"Prohibitin in adipose and immune functions","volume":"27","author":"Ande","year":"2016","journal-title":"Trends Endocrinol Metab"},{"issue":"46","key":"10.1016\/j.cancergen.2026.06.005_bib0144","doi-asserted-by":"crossref","first-page":"51593","DOI":"10.1021\/acsami.2c12291","article-title":"Identification of PHB2 as a potential biomarker of luminal A breast cancer cells using a cell-specific aptamer","volume":"14","author":"Liu","year":"2022","journal-title":"ACS Appl Mater Interfaces"},{"issue":"2","key":"10.1016\/j.cancergen.2026.06.005_bib0145","first-page":"355","article-title":"Identification of prohibitin as a potential biomarker for colorectal carcinoma based on proteomics technology","volume":"37","author":"Chen","year":"2010","journal-title":"Int J Oncol"},{"issue":"1","key":"10.1016\/j.cancergen.2026.06.005_bib0146","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1186\/s13046-021-02116-0","article-title":"STOML2 interacts with PHB through activating MAPK signaling pathway to promote colorectal cancer proliferation","volume":"40","author":"Ma","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.cancergen.2026.06.005_bib0147","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13046-016-0346-7","article-title":"Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer","volume":"35","author":"Cao","year":"2016","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.cancergen.2026.06.005_bib0148","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s12253-009-9242-1","article-title":"Increased expression of prohibitin and its relationship with poor prognosis in esophageal squamous cell carcinoma","volume":"16","author":"Ren","year":"2010","journal-title":"Pathol Oncol Res"},{"issue":"2","key":"10.1016\/j.cancergen.2026.06.005_bib0149","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s13277-014-2742-y","article-title":"Identification of prohibitin 1 as a potential prognostic biomarker in human pancreatic carcinoma using modified aqueous two-phase partition system combined with 2D-MALDI-TOF-TOF-MS\/MS","volume":"36","author":"Zhong","year":"2015","journal-title":"Tumour Biol"},{"issue":"8","key":"10.1016\/j.cancergen.2026.06.005_bib0150","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s00535-008-2208-3","article-title":"Prohibitin: a potential biomarker for tissue-based detection of gastric cancer","volume":"43","author":"Kang","year":"2008","journal-title":"J Gastroenterol"},{"issue":"8","key":"10.1016\/j.cancergen.2026.06.005_bib0151","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.7314\/APJCP.2012.13.8.3803","article-title":"Prohibitin induces apoptosis in BGC823 gastric cancer cells through the mitochondrial pathway","volume":"13","author":"Zhang","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"issue":"6","key":"10.1016\/j.cancergen.2026.06.005_bib0152","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.454","article-title":"Folate receptor \u03b1 increases chemotherapy resistance through stabilizing MDM2 in cooperation with PHB2 that is overcome by MORAb-202 in gastric cancer","volume":"11","author":"Sakai","year":"2021","journal-title":"Clin Transl Med"},{"issue":"1","key":"10.1016\/j.cancergen.2026.06.005_bib0153","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1038\/s41467-021-24108-6","article-title":"Suppression of mitochondrial ROS by prohibitin drives glioblastoma progression and therapeutic resistance","volume":"12","author":"Huang","year":"2021","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.cancergen.2026.06.005_bib0154","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/09553002.2025.2470203","article-title":"Prohibitin2 knockdown decreases glioma malignant phenotypes and radio-resistance by inhibiting mitophagy","volume":"101","author":"Xue","year":"2025","journal-title":"Int J Radiat Biol"},{"issue":"10","key":"10.1016\/j.cancergen.2026.06.005_bib0155","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.127130","article-title":"Prohibitin promotes de-differentiation and is a potential therapeutic target in neuroblastoma","volume":"4","author":"MacArthur","year":"2019","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.cancergen.2026.06.005_bib0156","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10571-010-9608-7","article-title":"Localization of prohibitin in the nuclear matrix and alteration of its expression during differentiation of human neuroblastoma SK-N-SH cells induced by retinoic acid","volume":"31","author":"Li","year":"2011","journal-title":"Cell Mol Neurobiol"},{"issue":"8","key":"10.1016\/j.cancergen.2026.06.005_bib0157","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.humpath.2011.10.006","article-title":"Prohibitin in squamous cell carcinoma of the lung: its expression and possible clinical significance","volume":"43","author":"Guo","year":"2012","journal-title":"Hum Pathol"},{"issue":"33","key":"10.1016\/j.cancergen.2026.06.005_bib0158","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1038\/onc.2017.93","article-title":"Targeting prohibitins with chemical ligands inhibits KRAS-mediated lung tumours","volume":"36","author":"Yurugi","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergen.2026.06.005_bib0159","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2023.116458","article-title":"Decreasing expression of prohibitin-2 lowers the oncogenicity of renal cell carcinoma cells by suppressing eIF4E-mediated oncogene translation via MNK inhibition","volume":"466","author":"Yang","year":"2023","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"10.1016\/j.cancergen.2026.06.005_bib0160","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.canlet.2008.02.047","article-title":"Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer","volume":"266","author":"Ummanni","year":"2008","journal-title":"Cancer Lett"},{"issue":"11","key":"10.1016\/j.cancergen.2026.06.005_bib0161","doi-asserted-by":"crossref","first-page":"6551","DOI":"10.21873\/anticanres.13021","article-title":"HSP27, ALDH6A1 and prohibitin act as a trio-biomarker to predict survival in late metastatic prostate cancer","volume":"38","author":"Cho","year":"2018","journal-title":"Anticancer Res"},{"issue":"2","key":"10.1016\/j.cancergen.2026.06.005_bib0162","first-page":"1147","article-title":"Prohibitin-2 negatively regulates AKT2 expression to promote prostate cancer cell migration","volume":"41","author":"Shen","year":"2018","journal-title":"Int J Mol Med"},{"issue":"1","key":"10.1016\/j.cancergen.2026.06.005_bib0163","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/CEJ.0b013e328354d351","article-title":"Prohibitin is an important biomarker for nasopharyngeal carcinoma progression and prognosis","volume":"22","author":"Liao","year":"2013","journal-title":"Eur J Cancer Prev"},{"issue":"3","key":"10.1016\/j.cancergen.2026.06.005_bib0164","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/cas.15662","article-title":"LPLUNC1 reduces glycolysis in nasopharyngeal carcinoma cells through the PHB1-p53\/c-myc axis","volume":"114","author":"Oyang","year":"2023","journal-title":"Cancer Sci"},{"issue":"1","key":"10.1016\/j.cancergen.2026.06.005_bib0165","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12885-018-4112-4","article-title":"Genetic determinants of sporadic breast cancer in Sri Lankan women","volume":"18","author":"Sirisena","year":"2018","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.cancergen.2026.06.005_bib0166","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/1535370220908257","article-title":"Prohibitin 1 in liver injury and cancer","volume":"245","author":"Barbier-Torres","year":"2020","journal-title":"Exp Biol Med (Maywood)"},{"issue":"3","key":"10.1016\/j.cancergen.2026.06.005_bib0167","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.febslet.2013.12.021","article-title":"The aberrant expression and localization of prohibitin during apoptosis of human cholangiocarcinoma Mz-ChA-1 cells","volume":"588","author":"Song","year":"2014","journal-title":"FEBS Lett"},{"issue":"4","key":"10.1016\/j.cancergen.2026.06.005_bib0168","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/hep.28964","article-title":"Prohibitin 1 suppresses liver cancer tumorigenesis in mice and human hepatocellular and cholangiocarcinoma cells","volume":"65","author":"Fan","year":"2017","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cancergen.2026.06.005_bib0169","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1002\/hep.23919","article-title":"Liver-specific deletion of prohibitin 1 results in spontaneous liver injury, fibrosis, and hepatocellular carcinoma in mice","volume":"52","author":"Ko","year":"2010","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.cancergen.2026.06.005_bib0170","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1002\/pmic.200900757","article-title":"Prohibitin deficiency blocks proliferation and induces apoptosis in human hepatoma cells: molecular mechanisms and functional implications","volume":"10","author":"S\u00e1nchez-Quiles","year":"2010","journal-title":"Proteomics"},{"issue":"1","key":"10.1016\/j.cancergen.2026.06.005_bib0171","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/toxsci\/kfq307","article-title":"Mitochondrial prohibitins and septin 9 are implicated in the onset of rat hepatocarcinogenesis","volume":"119","author":"Kakehashi","year":"2011","journal-title":"Toxicol Sci"},{"issue":"2","key":"10.1016\/j.cancergen.2026.06.005_bib0172","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11427-010-4130-1","article-title":"Up-regulation of prohibitin 1 is involved in the proliferation and migration of liver cancer cells","volume":"54","author":"Xu","year":"2011","journal-title":"Sci China Life Sci"},{"issue":"10","key":"10.1016\/j.cancergen.2026.06.005_bib0173","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/mc.22040","article-title":"Prohibitin-2 promotes hepatocellular carcinoma malignancy progression in hypoxia based on a label-free quantitative proteomics strategy","volume":"53","author":"Cheng","year":"2014","journal-title":"Mol Carcinog"},{"issue":"8","key":"10.1016\/j.cancergen.2026.06.005_bib0174","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1080\/15384101.2017.1295193","article-title":"Prohibitin promotes androgen receptor activation in ER-positive breast cancer","volume":"16","author":"Liu","year":"2017","journal-title":"Cell Cycle"},{"issue":"3","key":"10.1016\/j.cancergen.2026.06.005_bib0175","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/s12032-013-0614-8","article-title":"Immunohistochemical expression and mutation study of prohibitin gene in Indian female breast cancer cases","volume":"30","author":"Najm","year":"2013","journal-title":"Med Oncol"},{"issue":"4","key":"10.1016\/j.cancergen.2026.06.005_bib0176","first-page":"326","article-title":"The establishment of Raji drug-resistant cell line and analyses of prohibitin and miR-27a expression","volume":"36","author":"Zheng","year":"2015","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"26","key":"10.1016\/j.cancergen.2026.06.005_bib0177","doi-asserted-by":"crossref","first-page":"43114","DOI":"10.18632\/oncotarget.17810","article-title":"Accumulation of prohibitin is a common cellular response to different stressing stimuli and protects melanoma cells from ER stress and chemotherapy-induced cell death","volume":"8","author":"Tortelli","year":"2017","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.cancergen.2026.06.005_bib0178","article-title":"DIRAS1 Drives oxaliplatin resistance in colorectal cancer via PHB1-mediated mitochondrial homeostasis","volume":"14","author":"Long","year":"2025","journal-title":"Biology (Basel)"},{"issue":"1","key":"10.1016\/j.cancergen.2026.06.005_bib0179","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12929-020-00638-x","article-title":"A novel c-kit\/phospho-prohibitin axis enhances ovarian cancer stemness and chemoresistance via Notch3-PBX1 and \u03b2-catenin-ABCG2 signaling","volume":"27","author":"Fang","year":"2020","journal-title":"J Biomed Sci"},{"issue":"1","key":"10.1016\/j.cancergen.2026.06.005_bib0180","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12935-024-03415-0","article-title":"Key genes and molecular mechanisms related to Paclitaxel Resistance","volume":"24","author":"Alalawy","year":"2024","journal-title":"Cancer Cell Int"},{"issue":"6","key":"10.1016\/j.cancergen.2026.06.005_bib0181","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1073\/pnas.0910649107","article-title":"Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cells","volume":"107","author":"Patel","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1016\/j.cancergen.2026.06.005_bib0182","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083519","article-title":"Induction of paclitaxel resistance by ER\u03b1 mediated prohibitin mitochondrial-nuclear shuttling","volume":"8","author":"Dong","year":"2013","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.cancergen.2026.06.005_bib0183","first-page":"1221","article-title":"[Preliminary study of the prohibitin protein and paclitaxel resistance in ovarian cancer]","volume":"37","author":"Tang","year":"2012","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"issue":"5","key":"10.1016\/j.cancergen.2026.06.005_bib0184","first-page":"2106","article-title":"GOLPH3 promotes glioma progression by enhancing PHB2-mediated autophagy","volume":"11","author":"Wang","year":"2021","journal-title":"Am J Cancer Res"},{"issue":"12","key":"10.1016\/j.cancergen.2026.06.005_bib0185","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.3390\/biomedicines9121785","article-title":"Repurposing antipsychotics for cancer treatment","volume":"9","author":"Vlachos","year":"2021","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.cancergen.2026.06.005_bib0186","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1124\/molpharm.121.000334","article-title":"Fluorizoline blocks the interaction between prohibitin-2 and \u03b3-glutamylcyclotransferase and induces p21(Waf1\/Cip1) expression in MCF7 breast cancer cells","volume":"101","author":"Takagi","year":"2022","journal-title":"Mol Pharmacol"},{"issue":"8","key":"10.1016\/j.cancergen.2026.06.005_bib0187","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/ijc.29013","article-title":"Molecular mechanisms and anti-cancer aspects of the medicinal phytochemicals rocaglamides (=flavaglines)","volume":"137","author":"Li-Weber","year":"2015","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.cancergen.2026.06.005_bib0188","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/onc.2016.214","article-title":"Inhibition of the CRAF\/prohibitin interaction reverses CRAF-dependent resistance to vemurafenib","volume":"36","author":"Doudican","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergen.2026.06.005_bib0189","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112653","article-title":"Flavaglines as natural products targeting eIF4A and prohibitins: from traditional Chinese medicine to antiviral activity against coronaviruses","volume":"203","author":"Nebigil","year":"2020","journal-title":"Eur J Med Chem"},{"issue":"16_suppl","key":"10.1016\/j.cancergen.2026.06.005_bib0190","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1200\/JCO.2022.40.16_suppl.3081","article-title":"First-in-human phase 1\/2 dose escalation and expansion study evaluating first-in-class eIF4A inhibitor zotatifin in patients with solid tumors","volume":"40","author":"Meric-Bernstam","year":"2022","journal-title":"J Clin Oncol"},{"issue":"30","key":"10.1016\/j.cancergen.2026.06.005_bib0191","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2424286122","article-title":"eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancer","volume":"122","author":"Boyer","year":"2025","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"21","key":"10.1016\/j.cancergen.2026.06.005_bib0192","doi-asserted-by":"crossref","first-page":"8285","DOI":"10.1074\/jbc.RA118.002316","article-title":"Small-molecule screening yields a compound that inhibits the cancer-associated transcription factor Hes1 via the PHB2 chaperone","volume":"293","author":"Perron","year":"2018","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.cancergen.2026.06.005_bib0193","doi-asserted-by":"crossref","first-page":"982","DOI":"10.3390\/cancers13050982","article-title":"Rabdosianone I, a bitter diterpene from an oriental herb, suppresses thymidylate synthase expression by directly binding to ANT2 and PHB2","volume":"13","author":"Watanabe","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.cancergen.2026.06.005_bib0194","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/mc.23486","article-title":"Dihydroartemisinin synergistically enhances the cytotoxic effects of oxaliplatin in colon cancer by targeting the PHB2-RCHY1 mediated signaling pathway","volume":"62","author":"Wang","year":"2023","journal-title":"Mol Carcinog"},{"issue":"Pt 1","key":"10.1016\/j.cancergen.2026.06.005_bib0195","article-title":"Selection and identification of a prohibitin 2-binding DNA aptamer for tumor tissue imaging and targeted chemotherapy","volume":"259","author":"Qiao","year":"2024","journal-title":"Int J Biol Macromol"},{"issue":"25","key":"10.1016\/j.cancergen.2026.06.005_bib0196","doi-asserted-by":"crossref","first-page":"7779","DOI":"10.1073\/pnas.1505629112","article-title":"Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment","volume":"112","author":"Zhu","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.cancergen.2026.06.005_bib0197","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1021\/acsabm.4c00206","article-title":"Codelivery of CPT and siPHB1 with GSH\/ROS dual-responsive hybrid nanoparticles based on a [12]aneN(3)-derived lipid for synergistic lung cancer therapy","volume":"7","author":"Liang","year":"2024","journal-title":"ACS Appl Bio Mater"},{"key":"10.1016\/j.cancergen.2026.06.005_bib0198","doi-asserted-by":"crossref","DOI":"10.1016\/j.fsi.2023.108560","article-title":"Lamprey prohibitin 2 inhibits non-small cell lung carcinoma cell proliferation by down-regulating the expression and phosphorylation levels of cell cycle-associated proteins","volume":"134","author":"Zhang","year":"2023","journal-title":"Fish Shellfish Immunol"},{"issue":"1","key":"10.1016\/j.cancergen.2026.06.005_bib0199","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1038\/s41598-018-22212-0","article-title":"Lamprey Prohibitin2 arrest G2\/M phase transition of HeLa cells through down-regulating expression and phosphorylation level of Cell Cycle Proteins","volume":"8","author":"Shi","year":"2018","journal-title":"Sci Rep"},{"issue":"Pt 2","key":"10.1016\/j.cancergen.2026.06.005_bib0200","article-title":"Sensitive electrochemical immunosensor to detect prohibitin 2, a potential blood cancer biomarker","volume":"238","author":"Yun","year":"2022","journal-title":"Talanta"},{"key":"10.1016\/j.cancergen.2026.06.005_bib0201","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlb.2024.100146","article-title":"Liquid biopsy into the clinics: current evidence and future perspectives","volume":"4","author":"Boukovala","year":"2024","journal-title":"J Liq Biopsy"},{"issue":"39","key":"10.1016\/j.cancergen.2026.06.005_bib0202","doi-asserted-by":"crossref","first-page":"65445","DOI":"10.18632\/oncotarget.18920","article-title":"The prohibitin protein complex promotes mitochondrial stabilization and cell survival in hematologic malignancies","volume":"8","author":"Ross","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.cancergen.2026.06.005_bib0203","doi-asserted-by":"crossref","first-page":"398","DOI":"10.4251\/wjgo.v16.i2.398","article-title":"Prohibitin 1 inhibits cell proliferation and induces apoptosis via the p53-mediated mitochondrial pathway in vitro","volume":"16","author":"Shi","year":"2024","journal-title":"World J Gastrointest Oncol"},{"issue":"1","key":"10.1016\/j.cancergen.2026.06.005_bib0204","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13048-017-0325-4","article-title":"Prohibitin: targeting peptide coupled to ovarian cancer, luteinization and TGF-\u03b2 pathways","volume":"10","author":"El-Etreby","year":"2017","journal-title":"J Ovarian Res"},{"issue":"1","key":"10.1016\/j.cancergen.2026.06.005_bib0205","first-page":"26","article-title":"siRNA targeting prohibitins inhibits proliferation and promotes apoptosis of gastric carcinoma cell line SGC7901 in vitro and in vivo","volume":"60","author":"Zhang","year":"2014","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"1","key":"10.1016\/j.cancergen.2026.06.005_bib0206","article-title":"Role of PHB2 as a potential biomarker in pan-cancer: a multi-database analysis","volume":"15","author":"Zhang","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.cancergen.2026.06.005_bib0207","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154536","article-title":"PHB promotes bladder cancer cell epithelial-mesenchymal transition via the wnt\/\u03b2-catenin signaling pathway","volume":"247","author":"Jiang","year":"2023","journal-title":"Pathol Res Pract"},{"issue":"12","key":"10.1016\/j.cancergen.2026.06.005_bib0208","doi-asserted-by":"crossref","first-page":"9919","DOI":"10.3390\/ijms24129919","article-title":"Prohibitin links cell cycle, motility and invasion in prostate cancer cells","volume":"24","author":"Koushyar","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.cancergen.2026.06.005_bib0209","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/s41598-018-19917-7","article-title":"Prohibitin 2 localizes in nucleolus to regulate ribosomal RNA transcription and facilitate cell proliferation in RD cells","volume":"8","author":"Zhou","year":"2018","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.cancergen.2026.06.005_bib0210","article-title":"Spatial transcriptomics-aided localization for single-cell transcriptomics with STALocator","volume":"16","author":"Li","year":"2025","journal-title":"Cell Syst"},{"issue":"8","key":"10.1016\/j.cancergen.2026.06.005_bib0211","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.70192","article-title":"Next-generation proteolysis-targeting chimeras in precision oncology: multifunctional designs, emerging modalities, and translational prospects in targeted protein degradation","volume":"86","author":"Nafie","year":"2025","journal-title":"Drug Dev Res"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776226000736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776226000736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T07:24:52Z","timestamp":1787556292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776226000736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":211,"alternative-id":["S2210776226000736"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2026.06.005","relation":{},"ISSN":["2210-7762"],"issn-type":[{"value":"2210-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prohibitins in cancer: Multifaceted regulators of mitochondrial homeostasis, oncogenic signaling, tumor microenvironment, and therapeutic resistance","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2026.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}